Newsroom
July 1, 2021
Dr. Dimpy P. Shah, Population Health Sciences/Mays Cancer Center, was included within a story of the Rock Hill Herald addressing her research in which 94% of the 131 patients in the study produced antibodies three to four weeks after full vaccination, most of which had solid cancers as opposed to cancers in the blood. Read […]
July 1, 2021
Dr. Dimpy P. Shah, Population Health Sciences/Mays Cancer Center, was included within a story of the Belleville News-Democrat addressing her research in which 94% of the 131 patients in the study produced antibodies three to four weeks after full vaccination, most of which had solid cancers as opposed to cancers in the blood. Read story
July 1, 2021
Dr. Dimpy P. Shah, Population Health Sciences/Mays Cancer Center, was included within a story of the Charlotte Observer addressing her research in which 94% of the 131 patients in the study produced antibodies three to four weeks after full vaccination, most of which had solid cancers as opposed to cancers in the blood. Read story
July 1, 2021
Dr. Dimpy P. Shah, Population Health Sciences/ Mays Cancer Center, was included within a story of the San Luis Obispo Tribune addressing her research in which 94% of the 131 patients in the study produced antibodies three to four weeks after full vaccination, most of which had solid cancers as opposed to cancers in the […]
July 1, 2021
Dr. Dimpy P. Shah, Population Health Sciences/Mays Cancer Center, was included within a story in Yahoo addressing her research in which 94% of the 131 patients in the study produced antibodies three to four weeks after full vaccination, most of which had solid cancers as opposed to cancers in the blood. Read story
July 1, 2021
Dr. Jason Bowling, Infectious Diseases, discusses for KSAT 12 audiences the latest developments with the Delta variant and how the Covid-19 vaccines stand up against it; he refers to the partnership between University Health and UT Health San Antonio. Read story